196 related articles for article (PubMed ID: 37665998)
1. Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery : A Nationwide Cohort Study.
Kim DH; Lee SB; Park CM; Levin R; Metzger E; Bateman BT; Ely EW; Pandharipande PP; Pisani MA; Jones RN; Marcantonio ER; Inouye SK
Ann Intern Med; 2023 Sep; 176(9):1153-1162. PubMed ID: 37665998
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
Yoon HJ; Park KM; Choi WJ; Choi SH; Park JY; Kim JJ; Seok JH
BMC Psychiatry; 2013 Sep; 13():240. PubMed ID: 24074357
[TBL] [Abstract][Full Text] [Related]
3. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotics for delirium.
Lonergan E; Britton AM; Luxenberg J; Wyller T
Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.
Pasternak B; Svanström H; Ranthe MF; Melbye M; Hviid A
CNS Drugs; 2014 Oct; 28(10):963-73. PubMed ID: 24895158
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
9. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
10. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
11. Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea.
Shin JY; Choi NK; Lee J; Seong JM; Park MJ; Lee SH; Park BJ
PLoS One; 2015; 10(3):e0119931. PubMed ID: 25790285
[TBL] [Abstract][Full Text] [Related]
12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
13. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
[TBL] [Abstract][Full Text] [Related]
14. Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort study.
Chatterjee S; Chen H; Johnson ML; Aparasu RR
Drugs Aging; 2012 Oct; 29(10):807-17. PubMed ID: 23018582
[TBL] [Abstract][Full Text] [Related]
15. Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults-a propensity score matched cohort study.
Chyou TY; Nishtala R; Nishtala PS
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):692-700. PubMed ID: 32301237
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Gómez-Revuelta M; Pelayo-Terán JM; Juncal-Ruiz M; Vázquez-Bourgon J; Suárez-Pinilla P; Romero-Jiménez R; Setién Suero E; Ayesa-Arriola R; Crespo-Facorro B
Int J Neuropsychopharmacol; 2020 Apr; 23(4):217-229. PubMed ID: 31974576
[TBL] [Abstract][Full Text] [Related]
18. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study.
Park Y; Bateman BT; Kim DH; Hernandez-Diaz S; Patorno E; Glynn RJ; Mogun H; Huybrechts KF
BMJ; 2018 Mar; 360():k1218. PubMed ID: 29592958
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
[TBL] [Abstract][Full Text] [Related]
20. Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study.
Lao KSJ; Wong AYS; Wong ICK; Besag FMC; Chang WC; Lee EHM; Chen EYH; Blais JE; Chan EW
CNS Drugs; 2020 Feb; 34(2):197-206. PubMed ID: 31916101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
